Ginkgo Bioworks Files DEF 14A on Executive Compensation
Ticker: DNABW · Form: DEF 14A · Filed: Apr 29, 2025 · CIK: 1830214
| Field | Detail |
|---|---|
| Company | Ginkgo Bioworks Holdings, Inc. (DNABW) |
| Form Type | DEF 14A |
| Filed Date | Apr 29, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, corporate-governance, sec-filing
TL;DR
Ginkgo Bioworks DEF 14A out: Executive comp details for FY24, focusing on equity awards for PEO and Non-PEO/Neo members.
AI Summary
Ginkgo Bioworks Holdings, Inc. filed a DEF 14A on April 29, 2025, detailing executive compensation and corporate governance matters for the fiscal year ending December 31, 2024. The filing includes information on equity awards granted to its Principal Executive Officer (PEO) and Non-PEO/Neo members, with details on the fair value of outstanding awards and changes in fair value for prior year grants.
Why It Matters
This filing provides transparency into how Ginkgo Bioworks compensates its top executives, which can influence investor decisions and employee morale.
Risk Assessment
Risk Level: medium — DEF 14A filings can reveal information about executive compensation and corporate governance that may impact stock valuation and investor confidence.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for compensation details)
- 20250429 — Filing Date (Date the DEF 14A was submitted to the SEC)
Key Players & Entities
- Ginkgo Bioworks Holdings, Inc. (company) — Filer
- Soaring Eagle Acquisition Corp. (company) — Former Company Name
- Spinning Eagle Acquisition Corp. (company) — Former Company Name
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose of this DEF 14A filing is to provide information regarding executive compensation, director compensation, and other corporate governance matters for Ginkgo Bioworks Holdings, Inc.
What fiscal year does the compensation information primarily cover?
The compensation information primarily covers the fiscal year ending December 31, 2024.
Who are the main categories of individuals for whom equity award details are provided?
Equity award details are provided for the Principal Executive Officer (PEO) members and Non-PEO/Neo members.
What specific types of equity award information are detailed in the filing?
The filing details equity awards granted in summary compensation tables, adjusted equity awards excluding values reported in summary compensation tables, and the year-end fair value of outstanding and unvested equity awards.
When was Ginkgo Bioworks Holdings, Inc. formerly known as Soaring Eagle Acquisition Corp.?
Ginkgo Bioworks Holdings, Inc. was formerly known as Soaring Eagle Acquisition Corp. until a name change on February 10, 2021.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 29, 2025 regarding Ginkgo Bioworks Holdings, Inc. (DNABW).